174 related articles for article (PubMed ID: 2177632)
1. Insulin-like growth factor II acts as an autocrine growth and motility factor in human rhabdomyosarcoma tumors.
El-Badry OM; Minniti C; Kohn EC; Houghton PJ; Daughaday WH; Helman LJ
Cell Growth Differ; 1990 Jul; 1(7):325-31. PubMed ID: 2177632
[TBL] [Abstract][Full Text] [Related]
2. Autonomous growth of a human neuroblastoma cell line is mediated by insulin-like growth factor II.
El-Badry OM; Romanus JA; Helman LJ; Cooper MJ; Rechler MM; Israel MA
J Clin Invest; 1989 Sep; 84(3):829-39. PubMed ID: 2547840
[TBL] [Abstract][Full Text] [Related]
3. Suramin inhibits the growth of human rhabdomyosarcoma by interrupting the insulin-like growth factor II autocrine growth loop.
Minniti CP; Maggi M; Helman LJ
Cancer Res; 1992 Apr; 52(7):1830-5. PubMed ID: 1312901
[TBL] [Abstract][Full Text] [Related]
4. Urokinase type plasminogen activator receptor is involved in insulin-like growth factor-induced migration of rhabdomyosarcoma cells in vitro.
Gallicchio MA; Kaun C; Wojta J; Binder B; Bach LA
J Cell Physiol; 2003 Oct; 197(1):131-8. PubMed ID: 12942549
[TBL] [Abstract][Full Text] [Related]
5. Insulin-like growth factor receptor expression and function in human breast cancer.
Cullen KJ; Yee D; Sly WS; Perdue J; Hampton B; Lippman ME; Rosen N
Cancer Res; 1990 Jan; 50(1):48-53. PubMed ID: 2152773
[TBL] [Abstract][Full Text] [Related]
6. Insulin-like growth factor-II expression in carcinoma in colon cell lines: implications for autocrine actions.
Guo YS; Jin GF; Townsend CM; Zhang T; Sheng HM; Beauchamp RD; Thompson JC
J Am Coll Surg; 1995 Aug; 181(2):145-54. PubMed ID: 7627387
[TBL] [Abstract][Full Text] [Related]
7. A new marker for rhabdomyosarcoma. Insulin-like growth factor II.
Yun K
Lab Invest; 1992 Nov; 67(5):653-64. PubMed ID: 1434543
[TBL] [Abstract][Full Text] [Related]
8. Gastric cancer: the role of insulin-like growth factor 2 (IGF 2) and its receptors (IGF 1R and M6-P/IGF 2R).
Pavelić K; Kolak T; Kapitanović S; Radosević S; Spaventi S; Kruslin B; Pavelić J
J Pathol; 2003 Nov; 201(3):430-8. PubMed ID: 14595755
[TBL] [Abstract][Full Text] [Related]
9. Expression of insulin-like growth factor II in spontaneously immortalized rat mesothelial and spontaneous mesothelioma cells: a potential autocrine role of insulin-like growth factor II.
Rutten AA; Bermudez E; Stewart W; Everitt JI; Walker CL
Cancer Res; 1995 Aug; 55(16):3634-9. PubMed ID: 7627973
[TBL] [Abstract][Full Text] [Related]
10. Insulin-like growth factor II overexpression in myoblasts induces phenotypic changes typical of the malignant phenotype.
Minniti CP; Luan D; O'Grady C; Rosenfeld RG; Oh Y; Helman LJ
Cell Growth Differ; 1995 Mar; 6(3):263-9. PubMed ID: 7794794
[TBL] [Abstract][Full Text] [Related]
11. Soluble insulin-like growth factor II/mannose 6-phosphate receptor inhibits DNA synthesis in insulin-like growth factor II sensitive cells.
Scott CD; Weiss J
J Cell Physiol; 2000 Jan; 182(1):62-8. PubMed ID: 10567917
[TBL] [Abstract][Full Text] [Related]
12. Insulin-like growth factor-I can mediate autocrine proliferation of human small cell lung cancer cell lines in vitro.
Nakanishi Y; Mulshine JL; Kasprzyk PG; Natale RB; Maneckjee R; Avis I; Treston AM; Gazdar AF; Minna JD; Cuttitta F
J Clin Invest; 1988 Jul; 82(1):354-9. PubMed ID: 2839551
[TBL] [Abstract][Full Text] [Related]
13. Growth inhibition of human breast cancer cells in vitro with an antibody against the type I somatomedin receptor.
Arteaga CL; Osborne CK
Cancer Res; 1989 Nov; 49(22):6237-41. PubMed ID: 2553250
[TBL] [Abstract][Full Text] [Related]
14. Role for membrane and secreted insulin-like growth factor-binding protein-2 in the regulation of insulin-like growth factor action in lung tumors.
Reeve JG; Morgan J; Schwander J; Bleehen NM
Cancer Res; 1993 Oct; 53(19):4680-5. PubMed ID: 7691401
[TBL] [Abstract][Full Text] [Related]
15. Insulin-like growth factor-II: a novel autocrine growth factor modulating the apoptosis and maturation of umbilical cord blood erythroid progenitors.
Nagatomo T; Muta K; Ohga S; Ochiai M; Ohshima K; Hara T
Exp Hematol; 2008 Apr; 36(4):401-11. PubMed ID: 18261839
[TBL] [Abstract][Full Text] [Related]
16. Human osteosarcoma cell lines are dependent on insulin-like growth factor I for in vitro growth.
Kappel CC; Velez-Yanguas MC; Hirschfeld S; Helman LJ
Cancer Res; 1994 May; 54(10):2803-7. PubMed ID: 8168113
[TBL] [Abstract][Full Text] [Related]
17. Autocrine-paracrine regulation of human trophoblast invasiveness by insulin-like growth factor (IGF)-II and IGF-binding protein (IGFBP)-1.
Hamilton GS; Lysiak JJ; Han VK; Lala PK
Exp Cell Res; 1998 Oct; 244(1):147-56. PubMed ID: 9770358
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of proliferation in human MNNG/HOS osteosarcoma and SK-ES-1 Ewing sarcoma cell lines in vitro and in vivo by antagonists of growth hormone-releasing hormone: effects on insulin-like growth factor II.
Braczkowski R; Schally AV; Plonowski A; Varga JL; Groot K; Krupa M; Armatis P
Cancer; 2002 Oct; 95(8):1735-45. PubMed ID: 12365022
[TBL] [Abstract][Full Text] [Related]
19. Interferon-gamma inhibits DNA synthesis and insulin-like growth factor-II expression in human neuroblastoma cells.
Martin DM; Carlson RO; Feldman EL
J Neurosci Res; 1993 Apr; 34(5):489-501. PubMed ID: 8478984
[TBL] [Abstract][Full Text] [Related]
20. Cell proliferation and migration in glioblastoma multiforme cell lines are influenced by insulin-like growth factor I in vitro.
Schlenska-Lange A; Knüpfer H; Lange TJ; Kiess W; Knüpfer M
Anticancer Res; 2008; 28(2A):1055-60. PubMed ID: 18507054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
